47 minutes ago
Work-related stress associated with adverse cardiovascular health in diverse US adult population, indicating potential risk factor for CVD prevention.
1 hour ago
In this review of the month of October, some of the most notable advancements and news in the field of allergy were highlighted.
2 hours ago
Phase 3 data shows lumateperone 42 mg significantly delayed relapse in patients with schizophrenia vs placebo, with 63% reduced relapse risk and good tolerance.
3 hours ago
This nephrology month in review spotlights HCPLive’s coverage of ASN Kidney Week, the debut of a new podcast, and new research on IgA nephropathy.
7 hours ago
If approved, HLX14 would follow the first 2 denosumab biosimilar approvals in March 2024.